Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.18 USD | +4.03% | +7.92% | +12.62% |
Financials (USD)
Sales 2024 * | 19.11M | Sales 2025 * | 97.66M | Capitalization | 2.89B |
---|---|---|---|---|---|
Net income 2024 * | -165M | Net income 2025 * | -126M | EV / Sales 2024 * | 119 x |
Net cash position 2024 * | 618M | Net cash position 2025 * | 514M | EV / Sales 2025 * | 24.3 x |
P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-22.8
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | -3.09% | ||
1 week | +2.66% | ||
Current month | -11.99% | ||
1 month | -8.72% | ||
3 months | -9.13% | ||
6 months | +48.25% | ||
Current year | +8.54% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
BRD | Director/Board Member | 64 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 40.17 | +4.01% | 197 165 |
24-04-25 | 38.62 | -3.09% | 734,655 |
24-04-24 | 39.85 | +2.13% | 1,369,718 |
24-04-23 | 39.02 | +3.80% | 486,221 |
24-04-22 | 37.59 | +1.24% | 784,204 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.54% | 2.89B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.81% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- IDYA Stock